Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 3Terminated 2Completed 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Prostatic Neoplasms 25Breast Neoplasms 21Glioblastoma 19Carcinoma, Non-Small-Cell Lung 17Sarcoma 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Rectal Neoplasms 8Neoplasms 8Hodgkin Disease 8Head and Neck Neoplasms 8Brain Neoplasms 8Oropharyngeal Neoplasms 7Glioma 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Pancreatic Neoplasms 6Astrocytoma 6Triple Negative Breast Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Carcinoma, Squamous Cell 5Neoplasm Metastasis 4Melanoma 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Small Cell Lung Carcinoma 3Rhabdomyosarcoma 3Recurrence 3

Interventions

pembrolizumab 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Cisplatin 2entinostat 1bintrafusp alfa protein, human 1Vaccines 1Surveys and Questionnaires 1Specimen Handling 1Papillomavirus Vaccines 1Observation 1Nivolumab 1Ipilimumab 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1CTLA-4 Antigen 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Vulvar Neoplasms × Radiotherapy × Clear all
NCT04430699 2026-05-05

Cisplatin+Pembrolizumab+RT in Vulvar Cancer

Massachusetts General Hospital

Phase 2 Active not recruiting
24 enrolled
Gynecologic

Vulvar Neoplasms

NCT05051696 2024-06-04

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Xi'an Jiaotong University

Phase 2 Active not recruiting
120 enrolled
Gynecologic

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡